Source: Neuropsychopharmacology. Unidade: FMRP
Subjects: TRANSTORNOS PSICÓTICOS, ANSIEDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BHATTACHARYYA, Sagnik et al. Opposite effects of 'delta'-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology, v. 35, n. 3, p. 764-774, 2010Tradução . . Acesso em: 16 nov. 2024.APA
Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Wionton-Brown, T., et al. (2010). Opposite effects of 'delta'-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology, 35( 3), 764-774.NLM
Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Wionton-Brown T, Nosarti C, Carroll CMO', Seal M, Allen P, Mehta MA, Stone JM, Tunstall N, Giampietro V, Kapur S, Murray RM, Zuardi AW, Crippa JA de S, Atakan Z, McGuire PK. Opposite effects of 'delta'-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology. 2010 ; 35( 3): 764-774.[citado 2024 nov. 16 ]Vancouver
Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Wionton-Brown T, Nosarti C, Carroll CMO', Seal M, Allen P, Mehta MA, Stone JM, Tunstall N, Giampietro V, Kapur S, Murray RM, Zuardi AW, Crippa JA de S, Atakan Z, McGuire PK. Opposite effects of 'delta'-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology. 2010 ; 35( 3): 764-774.[citado 2024 nov. 16 ]
